Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide.
(2016) In EJNMMI Research 6(1).- Abstract
- Having performed analytical validation studies, we are now assessing the clinical utility of the upgraded automated Bone Scan Index (BSI) in metastatic castration-resistant prostate cancer (mCRPC). In the present study, we retrospectively evaluated the discriminatory strength of the automated BSI in predicting overall survival (OS) in mCRPC patients being treated with enzalutamide.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/8852825
- author
- Anand, Aseem LU ; Morris, Michael J ; Larson, Steven M ; Minarik, David LU ; Josefsson, Andreas ; Helgstrand, John T ; Oturai, Peter S ; Edenbrandt, Lars ; Røder, Martin Andreas and Bjartell, Anders LU
- organization
- publishing date
- 2016-03-09
- type
- Contribution to journal
- publication status
- published
- subject
- in
- EJNMMI Research
- volume
- 6
- issue
- 1
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:26960325
- scopus:84960939017
- wos:000371715100002
- pmid:26960325
- ISSN
- 2191-219X
- DOI
- 10.1186/s13550-016-0173-z
- language
- English
- LU publication?
- yes
- id
- c5a9bc82-d079-4775-be92-c8efc991a464 (old id 8852825)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26960325?dopt=Abstract
- date added to LUP
- 2016-04-04 09:25:34
- date last changed
- 2022-02-21 00:42:44
@article{c5a9bc82-d079-4775-be92-c8efc991a464, abstract = {{Having performed analytical validation studies, we are now assessing the clinical utility of the upgraded automated Bone Scan Index (BSI) in metastatic castration-resistant prostate cancer (mCRPC). In the present study, we retrospectively evaluated the discriminatory strength of the automated BSI in predicting overall survival (OS) in mCRPC patients being treated with enzalutamide.}}, author = {{Anand, Aseem and Morris, Michael J and Larson, Steven M and Minarik, David and Josefsson, Andreas and Helgstrand, John T and Oturai, Peter S and Edenbrandt, Lars and Røder, Martin Andreas and Bjartell, Anders}}, issn = {{2191-219X}}, language = {{eng}}, month = {{03}}, number = {{1}}, publisher = {{BioMed Central (BMC)}}, series = {{EJNMMI Research}}, title = {{Automated Bone Scan Index as a quantitative imaging biomarker in metastatic castration-resistant prostate cancer patients being treated with enzalutamide.}}, url = {{http://dx.doi.org/10.1186/s13550-016-0173-z}}, doi = {{10.1186/s13550-016-0173-z}}, volume = {{6}}, year = {{2016}}, }